JPRN-UMIN000017153CompletedPhase 2
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intake - A phase II study of neoadjuvant chemotherapy with DCS for esophageal cancer
Second Department of Surgery, Wakayama Medical University0 sites40 target enrollmentStarted: April 16, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1)Patients with concurrent other primary cancer requiring treatment (2)Pregnancy, possible pregnancy after delivery or breast feeding (3)Patients requiring systemic administration of steroid (4)Positive HBs antigen (5)Patients requiring flucytosine or phenytoin or warfarine administration (6)Patients for allergy of iodine (7)Patient with allergic response to anticancer drugs (docetaxel, cisplatin, S-1) (8)Severe peripheral nerve disorder (9)Patients with interstitial pneumonia or pulmonary fibrosis (10)Active infection (11)Patients with a history of myocardial infarction or unstable angina pectoris within the previous six months (12)Patients with uncontrolled hypertension or diabetes melitus
Investigators
Similar Trials
Completed
Phase 2
A phase II study of neoadjuvant chemotherapy with nab-paclitaxel followed by FEC in patitents with operable breast cancerbreast cancerJPRN-UMIN000030692kyushu Breast Cancer Study Group40
Completed
Phase 2
A Phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for Stage III gastric cancerStage III gastric cancerJPRN-UMIN000001584Department of Surgery Graduate School of Medicine, Kyoto University49
Recruiting
Phase 2
A phase II study of neoadjuvant chemotherapy with S-1 and oxaliplatin followed by surgery in cStageIII advanced gastric cancer patientsGastric cancerJPRN-UMIN000023405Wakayama Medical University, Second Department of Surgery48
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Completed
Not Applicable
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30